2026 ICD-10-CM Diagnosis Code T44.5X4APoisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter
T44.5X4A is a billable ICD-10-CM diagnosis code for poisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 917 through 918. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under External cause codes: intent of injury, undetermined; External cause codes: poisoning by drug; and Poisoning by drugs, initial encounter.
Code Identity
Code Classification
Coding GuidelinesGuidance
When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system (T44). Use the following options for the applicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Beclomethasone
an anti-inflammatory, synthetic glucocorticoid. it is used topically as an anti-inflammatory agent and in aerosol form for the treatment of asthma.Budesonide
a glucocorticoid used in the management of asthma, the treatment of various skin disorders, and allergic rhinitis.Budesonide, Formoterol Fumarate Drug Combination
a pharmaceutical preparation of budesonide and formoterol fumarate that is used as an anti-asthmatic agent and for the treatment of chronic obstructive pulmonary disease.Dobutamine
a catecholamine derivative with specificity for beta-1 adrenergic receptors. it is commonly used as a cardiotonic agent after cardiac surgery and during dobutamine stress echocardiography.Echocardiography, Stress
a method of recording heart motion and internal structures by combining ultrasonic imaging with exercise testing (exercise test) or pharmacologic stress.Epinephrine
the active sympathomimetic hormone from the adrenal medulla. it stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels. it is used in asthma and cardiac failure and to delay absorption of local anesthetics.Racepinephrine
a racemic mixture of d-epinephrine and l-epinephrine.Receptors, Adrenergic
cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. the two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. adrenergic receptors may also be classified according to the subtypes of g-proteins with which they bind; this scheme does not respect the alpha-beta distinction.Isoetharine
adrenergic beta-2 agonist used as bronchodilator for emphysema, bronchitis and asthma.Prenalterol
a partial adrenergic agonist with functional beta 1-receptor specificity and inotropic effect. it is effective in the treatment of acute cardiac failure, postmyocardial infarction low-output syndrome, shock, and reducing orthostatic hypotension in the shy-rager syndrome.Procaterol
a long-acting beta-2-adrenergic receptor agonist.Ritodrine
an adrenergic beta-2 agonist used to control premature labor.Xamoterol
a phenoxypropanolamine derivative that is a selective beta-1-adrenergic agonist.
Table of Drugs and ChemicalsClinical
Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.
| Substance | Accidental | Self-harm | Assault | Undetermined | Adverse Effect | Underdosing |
|---|---|---|---|---|---|---|
| Adrenaline | T44.5X1 | T44.5X2 | T44.5X3 | T44.5X4 | T44.5X5 | T44.5X6 |
| Angiotensin | T44.5X1 | T44.5X2 | T44.5X3 | T44.5X4 | T44.5X5 | T44.5X6 |
| Beclomethasone | T44.5X1 | T44.5X2 | T44.5X3 | T44.5X4 | T44.5X5 | T44.5X6 |
| Budesonide | T44.5X1 | T44.5X2 | T44.5X3 | T44.5X4 | T44.5X5 | T44.5X6 |
| Dobutamine | T44.5X1 | T44.5X2 | T44.5X3 | T44.5X4 | T44.5X5 | T44.5X6 |
| Epinephrine | T44.5X1 | T44.5X2 | T44.5X3 | T44.5X4 | T44.5X5 | T44.5X6 |
| Isoetharine | T44.5X1 | T44.5X2 | T44.5X3 | T44.5X4 | T44.5X5 | T44.5X6 |
| Prenalterol | T44.5X1 | T44.5X2 | T44.5X3 | T44.5X4 | T44.5X5 | T44.5X6 |
| Procaterol | T44.5X1 | T44.5X2 | T44.5X3 | T44.5X4 | T44.5X5 | T44.5X6 |
| Racepinefrin | T44.5X1 | T44.5X2 | T44.5X3 | T44.5X4 | T44.5X5 | T44.5X6 |
| Ritodrine | T44.5X1 | T44.5X2 | T44.5X3 | T44.5X4 | T44.5X5 | T44.5X6 |
| Xamoterol | T44.5X1 | T44.5X2 | T44.5X3 | T44.5X4 | T44.5X5 | T44.5X6 |
Patient EducationClinical
Poisoning
A poison is any substance that is harmful to your body. You might swallow it, inhale it, inject it, or absorb it through your skin. Any substance can be poisonous if too much is taken. Poisons can include:
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert T44.5X4A to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About T44.5X4AOverview
Is T44.5X4A a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What does the 7th character A in T44.5X4A mean?
The final character A marks the initial encounter: use it while the patient is receiving active treatment for poisoning by predominantly beta-adrenoreceptor agonists, undetermined, such as an emergency visit or first evaluation.
What MS-DRG does T44.5X4A group to?
When poisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter is the principal diagnosis on an inpatient stay, it groups to MS-DRG 917, 918, with relative weights from 0.8571 to 1.5684 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of T44.5X4A?
Under the General Equivalence Mappings, poisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter converts to ICD-9-CM 971.2 (poison-sympathomimetics) and E980.4 (undet pois-med agnt NEC). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.
